- Home
- IROQ vs ACHV Comparison
IROQ vs ACHV Comparison
Compare IROQ & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IROQ
- ACHV
- Stock Information
- Founded
- IROQ 1883
- ACHV N/A
- Country
- IROQ United States
- ACHV Canada
- Employees
- IROQ N/A
- ACHV N/A
- Industry
- IROQ Savings Institutions
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- IROQ Finance
- ACHV Health Care
- Exchange
- IROQ Nasdaq
- ACHV Nasdaq
- Market Cap
- IROQ 75.8M
- ACHV 72.5M
- IPO Year
- IROQ 2011
- ACHV N/A
- Fundamental
- Price
- IROQ N/A
- ACHV $1.99
- Analyst Decision
- IROQ
- ACHV Strong Buy
- Analyst Count
- IROQ 0
- ACHV 3
- Target Price
- IROQ N/A
- ACHV $14.33
- AVG Volume (30 Days)
- IROQ 2.0K
- ACHV 193.4K
- Earning Date
- IROQ 04-29-2025
- ACHV 05-08-2025
- Dividend Yield
- IROQ 1.70%
- ACHV N/A
- EPS Growth
- IROQ 56.77
- ACHV N/A
- EPS
- IROQ 0.95
- ACHV N/A
- Revenue
- IROQ $24,226,000.00
- ACHV N/A
- Revenue This Year
- IROQ N/A
- ACHV N/A
- Revenue Next Year
- IROQ N/A
- ACHV N/A
- P/E Ratio
- IROQ $24.76
- ACHV N/A
- Revenue Growth
- IROQ 8.37
- ACHV N/A
- 52 Week Low
- IROQ $14.85
- ACHV $1.84
- 52 Week High
- IROQ $25.76
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- IROQ 46.42
- ACHV 31.53
- Support Level
- IROQ $23.01
- ACHV $1.98
- Resistance Level
- IROQ $24.20
- ACHV $2.28
- Average True Range (ATR)
- IROQ 0.40
- ACHV 0.24
- MACD
- IROQ -0.06
- ACHV -0.02
- Stochastic Oscillator
- IROQ 21.34
- ACHV 15.62
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.